ED-71 Chugai

Curr Opin Investig Drugs. 2004 Apr;5(4):441-7.

Abstract

Chugai is developing ED-71, an orally available vitamin D3 derivative, for the potential treatment of osteoporosis. By December 2003, the compound had entered phase III trial for the prevention of fracture.

Publication types

  • Review

MeSH terms

  • Animals
  • Calcitriol / analogs & derivatives*
  • Calcitriol / chemistry*
  • Calcitriol / pharmacology
  • Calcitriol / therapeutic use
  • Clinical Trials, Phase II as Topic
  • Humans
  • Osteoporosis / drug therapy
  • Osteoporosis / prevention & control
  • Receptors, Calcitriol / antagonists & inhibitors*
  • Structure-Activity Relationship
  • Vitamin D / analogs & derivatives

Substances

  • Receptors, Calcitriol
  • Vitamin D
  • Calcitriol
  • eldecalcitol